355 related articles for article (PubMed ID: 10201012)
1. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
Moustapha A; Gupta A; Robinson K; Arheart K; Jacobsen DW; Schreiber MJ; Dennis VW
Kidney Int; 1999 Apr; 55(4):1470-5. PubMed ID: 10201012
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
[TBL] [Abstract][Full Text] [Related]
3. [Effect of folic acid supplementation on total homocysteine levels in hemodialysis patients].
Armada E; Pérez Melón C; Otero A; Gayoso P; Rodríguez M; Esteban Morcillo J
Nefrologia; 2001; 21(2):167-73. PubMed ID: 11464650
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
Cetin O; Bekpinar S; Unlucerci Y; Turkmen A; Bayram C; Ulutin T
Clin Nephrol; 2006 Feb; 65(2):97-102. PubMed ID: 16509458
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.
Robinson K; Gupta A; Dennis V; Arheart K; Chaudhary D; Green R; Vigo P; Mayer EL; Selhub J; Kutner M; Jacobsen DW
Circulation; 1996 Dec; 94(11):2743-8. PubMed ID: 8941098
[TBL] [Abstract][Full Text] [Related]
6. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase genotype, vitamin B12, and folate influence plasma homocysteine in hemodialysis patients.
Nakamura T; Saionji K; Hiejima Y; Hirayama H; Tago K; Takano H; Tajiri M; Hayashi K; Kawabata M; Funamizu M; Makita Y; Hata A
Am J Kidney Dis; 2002 May; 39(5):1032-9. PubMed ID: 11979347
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine, vitamin B12, and serum and erythrocyte folate in peritoneal dialysis and hemodialysis patients.
De Vecchi AF; Bamonti-Catena F; Finazzi S; Campolo J; Taioli E; Novembrino C; Colucci P; Accinni R; De Franceschi M; Fasano MA; Maiolo AT
Perit Dial Int; 2000; 20(2):169-73. PubMed ID: 10809239
[TBL] [Abstract][Full Text] [Related]
9. What is the meaning of homocysteine in patients on dialysis?
Silva de Almeida CC; Guerra DC; Vannucchi MT; Geleilete TJ; Vannucchi H; Chiarello PG
J Ren Nutr; 2011 Sep; 21(5):394-400. PubMed ID: 21439851
[TBL] [Abstract][Full Text] [Related]
10. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
[TBL] [Abstract][Full Text] [Related]
11. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
Lovcić V; Kes P; Zeljko R; Kusec V
Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
[TBL] [Abstract][Full Text] [Related]
12. Homocysteine, vitamin B12, serum and erythrocyte folate in peritoneal dialysis patients.
De Vecchi AF; Bamonti-Catena F; Finazzi S; Patrosso C; Taioli E; Novembrino C; Colucci P; Lando G; De Franceschi M; Marocchi A; Maiolo AT
Clin Nephrol; 2001 Apr; 55(4):313-7. PubMed ID: 11334318
[TBL] [Abstract][Full Text] [Related]
13. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.
Bostom AG; Shemin D; Lapane KL; Nadeau MR; Sutherland P; Chan J; Rozen R; Yoburn D; Jacques PF; Selhub J; Rosenberg IH
Atherosclerosis; 1996 Jun; 123(1-2):193-202. PubMed ID: 8782850
[TBL] [Abstract][Full Text] [Related]
14. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
Hong SY; Yang DH; Chang SK
Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
[TBL] [Abstract][Full Text] [Related]
15. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
16. Plasma homocysteine concentration changes after renal transplantation in children.
Merouani A; Delvin EE; Genest J; Rozen R; Lambert M
Pediatr Nephrol; 2002 Jul; 17(7):520-3. PubMed ID: 12172766
[TBL] [Abstract][Full Text] [Related]
17. Homocysteinemia and vascular disease in end-stage renal disease.
Dennis VW; Robinson K
Kidney Int Suppl; 1996 Dec; 57():S11-7. PubMed ID: 8941916
[TBL] [Abstract][Full Text] [Related]
18. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD.
Sjöberg B; Anderstam B; Suliman M; Alvestrand A
Am J Kidney Dis; 2006 Jan; 47(1):60-71. PubMed ID: 16377386
[TBL] [Abstract][Full Text] [Related]
19. [Hyperhomocysteinemia and schizophrenia: case control study].
Mabrouk H; Douki W; Mechri A; Younes MK; Omezzine A; Bouslama A; Gaha L; Najjar MF
Encephale; 2011 Sep; 37(4):308-13. PubMed ID: 21981892
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic alcohol consumption on total plasma homocysteine level in rats.
Stickel F; Choi SW; Kim YI; Bagley PJ; Seitz HK; Russell RM; Selhub J; Mason JB
Alcohol Clin Exp Res; 2000 Mar; 24(3):259-64. PubMed ID: 10776661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
